Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Zydus Amplitude receives CE mark for its robotic surgical system Andy .
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences' subsidiary Zydus Amplitude has received the CE mark for its robotic surgical system named Andy. The CE mark is a European certification indicating the product meets EU regulatory standards for safety, health, and environmental requirements, allowing it to be marketed and sold in the European Economic Area. This approval opens the door for commercial launch and sales of the robotic surgical system in European markets.
Positive for shareholders as it validates Zydus's medical technology capabilities and unlocks a new revenue stream from the European market for the robotic surgery business, potentially strengthening long-term growth prospects.